Discover 468 paid clinical trials in Grand Rapids, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 468
Prevail Global Study
for
Coronary Artery Disease
Location: Grand Rapids MI, Ann Arbor MI, Ypsilanti MI, Chicago IL,
Sponsor: Medtronic Vascular
Sex: All
Age: 18+
Code: NCT06535854
Recruiting
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
for
Aortic Aneurysm, Abdominal
Location: Grand Rapids MI, Pittsburgh PA, New York NY, Norfolk VA,
Sponsor: FCRE (Foundation for Cardiovascular Research and Education)
Sex: All
Age: 18+
Code: NCT04503395
Recruiting
Pompe Pregnancy Sub-Registry
for
Glycogen Storage Disease Type II (GSD-II),
Location: Grand Rapids MI, Indianapolis IN, Dublin OH,
Sponsor: Genzyme, a Sanofi Company
Sex: Female
Age: 0+
Code: NCT00567073
Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Grand Rapids MI, Kalamazoo MI, Lansing MI, Flint MI,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase 3, Recruiting
Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)
for
Metastatic Castration-resistant Prostate Cancer
Location: Grand Rapids MI
Sponsor: BAMF Health
Sex: Male
Age: 18+
Code: NCT05823402
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Total Body PET-CT Imaging of Prostate Cancer Using Illuccix
for
Metastatic Castration-resistant Prostate Cancer
Location: Grand Rapids MI
Sponsor: BAMF Health
Sex: Male
Age: 18+
Code: NCT05558956
Early Phase 1, Recruiting
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
for
Lung Transplant Rejection
Location: Grand Rapids MI, Ann Arbor MI, Chicago IL, Maywood IL,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06082037
Phase 3, Recruiting
Registry for Stage 2 Type 1 Diabetes
for
Type 1 Diabetes
Location: Grand Rapids MI, Ann Arbor MI, Farmington Hills MI,
Sponsor: Sanofi
Sex: All
Age: 0+
Code: NCT06481904
Recruiting
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Location: Grand Rapids MI, Farmington Hills MI, Columbus OH,
Sponsor: ALX Oncology Inc.
Sex: All
Age: 18+
Code: NCT07085091
Phase 1, Recruiting
Pompe Disease Registry Protocol
for
Glycogen Storage Disease Type II, Pompe Disease
Location: Grand Rapids MI, Ann Arbor MI, Chicago IL, Detroit MI,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00231400
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: Grand Rapids MI, Ann Arbor MI, Milwaukee WI, Chicago IL,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
for
Crohn's Disease
Location: Wyoming MI, Iowa City IA, St Louis MO, Harrisburg PA,
Sponsor: Sanofi
Sex: All
Age: 18 - 70+
Code: NCT06958536
Phase 2, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Wyoming MI, Gurnee IL, Glenview IL, Chicago IL,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184996
Phase 3, Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Wyoming MI, Gurnee IL, Westlake OH, London, Columbus OH,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07185009
Phase 3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Wyoming MI, Novi MI, Milwaukee WI, Gurnee IL,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184931
Phase 3, Recruiting
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Grand Rapids MI, Chicago IL, Fort Wayne IN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase 1, Recruiting
A Study of MGC028 in Participants With Advanced Solid Tumors
Location: Grand Rapids MI, New York NY, Boston MA, San Antonio TX,
Sponsor: MacroGenics
Sex: All
Age: 18+
Code: NCT06723236
Phase 1, Recruiting
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
for
Solid Malignancies, Hematologic Malignancies
Location: Grand Rapids MI, Ann Arbor MI, Canton OH, Iowa City IA,
Sponsor: Immunome, Inc.
Sex: All
Age: 18+
Code: NCT06823167
Phase 1, Recruiting
A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML
for
AML (Acute Myeloid Leukemia)
Location: Grand Rapids MI, Nashville TN, New York NY,
Sponsor: Charm Therapeutics
Sex: All
Age: 18+
Code: NCT07751991
Phase 1, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: Grand Rapids MI, Chicago IL, Nashville TN, Fairfax VA,